Nanopharmaceuticals (part 1): products on the market
Volkmar Weissig,1 Tracy K Pettinger,2 Nicole Murdock3 1Department of Pharmaceutical Sciences, Midwestern University College of Pharmacy Glendale, Glendale, AZ, USA; 2Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, Idaho State University, Pocatello, ID, USA; 3Depar...
Guardado en:
Autores principales: | Weissig V, Pettinger TK, Murdock N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1926aedc638440418448533da8e55d08 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanopharmaceuticals (part 2): products in the pipeline
por: Weissig V, et al.
Publicado: (2015) -
Development and evaluation of vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical
por: Shen R, et al.
Publicado: (2016) -
Bombesin Peptide Conjugated Water-Soluble Chitosan Gallate—A New Nanopharmaceutical Architecture for the Rapid One-Pot Synthesis of Prostate Tumor Targeted Gold Nanoparticles
por: Tangthong T, et al.
Publicado: (2021) -
Patents, Drug Delivery and Public Health Protection: Health Risk Management for Nanopharmaceuticals
por: da Silva Sant'Anna,Leonardo, et al.
Publicado: (2013) -
Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications
por: Ghosh IN, et al.
Publicado: (2013)